Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has provided an announcement.
Shandong Xinhua Pharmaceutical Company Limited has announced proposed amendments to its Articles of Association following an increase in its issued share capital due to the exercise of options under its Share Option Scheme. Additionally, the company has absorbed Ronghua (Zibo) Property Services Co., Ltd., expanding its business scope to include property management and real estate rental services. These changes necessitate revisions to the company’s Articles of Association, which will be subject to shareholder approval at a general meeting.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Stock Exchange of Hong Kong.
YTD Price Performance: -0.69%
Average Trading Volume: 3,436,257
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$9.16B
Learn more about 0719 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue